社区
首页
集团介绍
社区
资讯
行情
学堂
TigerGPT
登录
注册
Prosperity
IP属地:未知
+关注
帖子 · 85
帖子 · 85
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
Prosperity
Prosperity
·
2021-09-01
Like and comment
Beyond Meat Stock Turns Higher After Don Lee Farms Trade Secrets Case Ruling
Beyond Meat (BYND) Meat, Inc. Report shares edged higher Tuesday after the plant-based food producer
Beyond Meat Stock Turns Higher After Don Lee Farms Trade Secrets Case Ruling
看
395
回复
1
点赞
7
编组 21备份 2
分享
举报
Prosperity
Prosperity
·
2021-08-26
Like and comment
非常抱歉,此主贴已删除
看
741
回复
3
点赞
4
编组 21备份 2
分享
举报
Prosperity
Prosperity
·
2021-08-23
Like and comment
非常抱歉,此主贴已删除
看
483
回复
2
点赞
7
编组 21备份 2
分享
举报
Prosperity
Prosperity
·
2021-08-19
Like and comment
非常抱歉,此主贴已删除
看
740
回复
2
点赞
2
编组 21备份 2
分享
举报
Prosperity
Prosperity
·
2021-08-13
Like and comment
BioNTech, Moderna Rise On Nod To Booster For Those With Weak Immunity
BioNTech and Moderna stocks were up in early trading following the FDA authorizing Covid-19 booster
BioNTech, Moderna Rise On Nod To Booster For Those With Weak Immunity
看
378
回复
1
点赞
4
编组 21备份 2
分享
举报
Prosperity
Prosperity
·
2021-08-04
Like and comment
非常抱歉,此主贴已删除
看
721
回复
2
点赞
9
编组 21备份 2
分享
举报
Prosperity
Prosperity
·
2021-08-02
Like and comment
非常抱歉,此主贴已删除
看
765
回复
1
点赞
4
编组 21备份 2
分享
举报
Prosperity
Prosperity
·
2021-07-29
Like and comment
非常抱歉,此主贴已删除
看
574
回复
1
点赞
10
编组 21备份 2
分享
举报
Prosperity
Prosperity
·
2021-07-26
Like and comment
非常抱歉,此主贴已删除
看
995
回复
评论
点赞
7
编组 21备份 2
分享
举报
Prosperity
Prosperity
·
2021-07-25
Like and comment
非常抱歉,此主贴已删除
看
869
回复
1
点赞
2
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3574073567796453","uuid":"3574073567796453","gmtCreate":1611047225330,"gmtModify":1745827460051,"name":"Prosperity","pinyin":"prosperity","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/f04cc1d16570f51a2292afc487839365","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":29,"headSize":7,"tweetSize":85,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.03.18","exceedPercentage":"93.45%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-2","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"资深虎友","description":"加入老虎社区1000天","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.10.17","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.30%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":7,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":816271186,"gmtCreate":1630505545245,"gmtModify":1631890206709,"author":{"id":"3574073567796453","authorId":"3574073567796453","name":"Prosperity","avatar":"https://static.tigerbbs.com/f04cc1d16570f51a2292afc487839365","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574073567796453","authorIdStr":"3574073567796453"},"themes":[],"htmlText":"Like and comment","listText":"Like and comment","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/816271186","repostId":"1150832177","repostType":4,"repost":{"id":"1150832177","kind":"news","pubTimestamp":1630504818,"share":"https://www.laohu8.com/m/news/1150832177?lang=&edition=full","pubTime":"2021-09-01 22:00","market":"us","language":"en","title":"Beyond Meat Stock Turns Higher After Don Lee Farms Trade Secrets Case Ruling","url":"https://stock-news.laohu8.com/highlight/detail?id=1150832177","media":"Thestreet","summary":"Beyond Meat (BYND) Meat, Inc. Report shares edged higher Tuesday after the plant-based food producer","content":"<p>Beyond Meat (<b>BYND</b>) Meat, Inc. Report shares edged higher Tuesday after the plant-based food producer said it received a favorable ruling in an ongoing trade secrets case with Don Lee Farms.</p>\n<p>Beyond Meat said Los Angeles Superior Court Judge Holly J. Fujie ruled that two key claims of misappropriation of trade secrets and unfair competition raised by Don Lee Farms -- a former manufacturing partner -- would not proceed to trial, which is set for September 22.</p>\n<p>Earlier this year, California's Superior Court ruled the Beyond Meat pay around $400,000 owed to Don Lee farms as part of the contract it severed in 2017.</p>\n<p>\"Although Don Lee Farms had no prior experience manufacturing plant-based meat products, it claimed it owned the procedures for manufacturing Beyond Meat’s proprietary plant-based meat products,\" Beyond Meat said in a statement. \"The Court has now outright rejected that claim.\"</p>\n<p>Beyond Meat shares were marked 0.46% higher in pre-market trading, reversing an earlier decline, to indicate an opening bell price of $120.85 each.</p>\n<p>Earlier this month, Beyond Meat posted a wider-than-expected second quarter loss of 31 cents per share, on sales of $149.4 million.</p>\n<p>It also forecast softer third quarter sales of between $120 million to $140 million as restaurants grow more cautious on food orders amid the summer rise in Delta-variant coronavirus infections.</p>\n<p>\"We believe it's prudent to call out that due to recent increases in COVID-19 infection rates stemming from the Delta variant, we're seeing some early signs of a return to a more cautionary stance across certain parts of the Foodservice sector,\" CFO Philip Hardin told investors on August 6. .</p>\n<p>\"There continues to be uncertainty, particularly in Foodservice channels related to the COVID-19 infection rates in the Delta variant, as well as reimplementation of safety measures in certain jurisdictions and potential impact on customer demand levels,\" he noted. \"Although we generally expect to see continued year-over-year growth in our Foodservice business for the balance of the year, albeit at a more moderate pace than what we saw in Q2.\"</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Beyond Meat Stock Turns Higher After Don Lee Farms Trade Secrets Case Ruling</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBeyond Meat Stock Turns Higher After Don Lee Farms Trade Secrets Case Ruling\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-01 22:00 GMT+8 <a href=https://www.thestreet.com/investing/beyond-meat-stock-turns-higher-after-don-lee-farms-case-ruling><strong>Thestreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Beyond Meat (BYND) Meat, Inc. Report shares edged higher Tuesday after the plant-based food producer said it received a favorable ruling in an ongoing trade secrets case with Don Lee Farms.\nBeyond ...</p>\n\n<a href=\"https://www.thestreet.com/investing/beyond-meat-stock-turns-higher-after-don-lee-farms-case-ruling\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.thestreet.com/investing/beyond-meat-stock-turns-higher-after-don-lee-farms-case-ruling","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1150832177","content_text":"Beyond Meat (BYND) Meat, Inc. Report shares edged higher Tuesday after the plant-based food producer said it received a favorable ruling in an ongoing trade secrets case with Don Lee Farms.\nBeyond Meat said Los Angeles Superior Court Judge Holly J. Fujie ruled that two key claims of misappropriation of trade secrets and unfair competition raised by Don Lee Farms -- a former manufacturing partner -- would not proceed to trial, which is set for September 22.\nEarlier this year, California's Superior Court ruled the Beyond Meat pay around $400,000 owed to Don Lee farms as part of the contract it severed in 2017.\n\"Although Don Lee Farms had no prior experience manufacturing plant-based meat products, it claimed it owned the procedures for manufacturing Beyond Meat’s proprietary plant-based meat products,\" Beyond Meat said in a statement. \"The Court has now outright rejected that claim.\"\nBeyond Meat shares were marked 0.46% higher in pre-market trading, reversing an earlier decline, to indicate an opening bell price of $120.85 each.\nEarlier this month, Beyond Meat posted a wider-than-expected second quarter loss of 31 cents per share, on sales of $149.4 million.\nIt also forecast softer third quarter sales of between $120 million to $140 million as restaurants grow more cautious on food orders amid the summer rise in Delta-variant coronavirus infections.\n\"We believe it's prudent to call out that due to recent increases in COVID-19 infection rates stemming from the Delta variant, we're seeing some early signs of a return to a more cautionary stance across certain parts of the Foodservice sector,\" CFO Philip Hardin told investors on August 6. .\n\"There continues to be uncertainty, particularly in Foodservice channels related to the COVID-19 infection rates in the Delta variant, as well as reimplementation of safety measures in certain jurisdictions and potential impact on customer demand levels,\" he noted. \"Although we generally expect to see continued year-over-year growth in our Foodservice business for the balance of the year, albeit at a more moderate pace than what we saw in Q2.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":395,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":810562383,"gmtCreate":1629987114342,"gmtModify":1704954230159,"author":{"id":"3574073567796453","authorId":"3574073567796453","name":"Prosperity","avatar":"https://static.tigerbbs.com/f04cc1d16570f51a2292afc487839365","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574073567796453","authorIdStr":"3574073567796453"},"themes":[],"htmlText":"Like and comment","listText":"Like and comment","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/810562383","repostId":"2162857097","repostType":4,"isVote":1,"tweetType":1,"viewCount":741,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":835404623,"gmtCreate":1629729900062,"gmtModify":1631890206714,"author":{"id":"3574073567796453","authorId":"3574073567796453","name":"Prosperity","avatar":"https://static.tigerbbs.com/f04cc1d16570f51a2292afc487839365","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574073567796453","authorIdStr":"3574073567796453"},"themes":[],"htmlText":"Like and comment","listText":"Like and comment","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/835404623","repostId":"2161747692","repostType":4,"isVote":1,"tweetType":1,"viewCount":483,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":838988210,"gmtCreate":1629365400130,"gmtModify":1631890206716,"author":{"id":"3574073567796453","authorId":"3574073567796453","name":"Prosperity","avatar":"https://static.tigerbbs.com/f04cc1d16570f51a2292afc487839365","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574073567796453","authorIdStr":"3574073567796453"},"themes":[],"htmlText":"Like and comment","listText":"Like and comment","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/838988210","repostId":"1186292485","repostType":4,"isVote":1,"tweetType":1,"viewCount":740,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":897033656,"gmtCreate":1628862237075,"gmtModify":1631890206720,"author":{"id":"3574073567796453","authorId":"3574073567796453","name":"Prosperity","avatar":"https://static.tigerbbs.com/f04cc1d16570f51a2292afc487839365","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574073567796453","authorIdStr":"3574073567796453"},"themes":[],"htmlText":"Like and comment","listText":"Like and comment","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/897033656","repostId":"1141206470","repostType":4,"repost":{"id":"1141206470","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628861824,"share":"https://www.laohu8.com/m/news/1141206470?lang=&edition=full","pubTime":"2021-08-13 21:37","market":"us","language":"en","title":"BioNTech, Moderna Rise On Nod To Booster For Those With Weak Immunity","url":"https://stock-news.laohu8.com/highlight/detail?id=1141206470","media":"Tiger Newspress","summary":"BioNTech and Moderna stocks were up in early trading following the FDA authorizing Covid-19 booster ","content":"<p>BioNTech and Moderna stocks were up in early trading following the FDA authorizing Covid-19 booster shots for people with weak immunity.</p>\n<p>BioNTech was up 3% and Moderna gained 3%, while Pfizer , which has jointly developed the two-dose mRNA vaccine with BioNTech, was up 2%.</p>\n<p><img src=\"https://static.tigerbbs.com/18d1d9877f2ba36a61eaf23f41b8914f\" tg-width=\"898\" tg-height=\"607\" referrerpolicy=\"no-referrer\"></p>\n<p>Late on Thursday, the U.S. Food and Drug Administration authorized a booster doseof vaccines from Pfizer Inc(PFE.N)and Moderna Inc(MRNA.O)for people with compromised immune systems.</p>\n<p>Pfizer, along with its German partner BioNTech , and Moderna have together locked up over $60 billion in sales of the shots just in 2021 and 2022. The agreements include supply of the initial two doses of their vaccines as well as billions of dollars in potential boosters for wealthy nations.</p>\n<p>Going forward, analysts have forecast revenue of over $6.6 billion for the Pfizer/BioNTech shot and $7.6 billion for Moderna in 2023, mostly from booster sales. They eventually see the annual market settling at around $5 billion or higher, with additional drugmakers competing for those sales.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BioNTech, Moderna Rise On Nod To Booster For Those With Weak Immunity</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioNTech, Moderna Rise On Nod To Booster For Those With Weak Immunity\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-13 21:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BioNTech and Moderna stocks were up in early trading following the FDA authorizing Covid-19 booster shots for people with weak immunity.</p>\n<p>BioNTech was up 3% and Moderna gained 3%, while Pfizer , which has jointly developed the two-dose mRNA vaccine with BioNTech, was up 2%.</p>\n<p><img src=\"https://static.tigerbbs.com/18d1d9877f2ba36a61eaf23f41b8914f\" tg-width=\"898\" tg-height=\"607\" referrerpolicy=\"no-referrer\"></p>\n<p>Late on Thursday, the U.S. Food and Drug Administration authorized a booster doseof vaccines from Pfizer Inc(PFE.N)and Moderna Inc(MRNA.O)for people with compromised immune systems.</p>\n<p>Pfizer, along with its German partner BioNTech , and Moderna have together locked up over $60 billion in sales of the shots just in 2021 and 2022. The agreements include supply of the initial two doses of their vaccines as well as billions of dollars in potential boosters for wealthy nations.</p>\n<p>Going forward, analysts have forecast revenue of over $6.6 billion for the Pfizer/BioNTech shot and $7.6 billion for Moderna in 2023, mostly from booster sales. They eventually see the annual market settling at around $5 billion or higher, with additional drugmakers competing for those sales.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","PFE":"辉瑞","MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1141206470","content_text":"BioNTech and Moderna stocks were up in early trading following the FDA authorizing Covid-19 booster shots for people with weak immunity.\nBioNTech was up 3% and Moderna gained 3%, while Pfizer , which has jointly developed the two-dose mRNA vaccine with BioNTech, was up 2%.\n\nLate on Thursday, the U.S. Food and Drug Administration authorized a booster doseof vaccines from Pfizer Inc(PFE.N)and Moderna Inc(MRNA.O)for people with compromised immune systems.\nPfizer, along with its German partner BioNTech , and Moderna have together locked up over $60 billion in sales of the shots just in 2021 and 2022. The agreements include supply of the initial two doses of their vaccines as well as billions of dollars in potential boosters for wealthy nations.\nGoing forward, analysts have forecast revenue of over $6.6 billion for the Pfizer/BioNTech shot and $7.6 billion for Moderna in 2023, mostly from booster sales. They eventually see the annual market settling at around $5 billion or higher, with additional drugmakers competing for those sales.","news_type":1},"isVote":1,"tweetType":1,"viewCount":378,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":890868925,"gmtCreate":1628092421367,"gmtModify":1631890206721,"author":{"id":"3574073567796453","authorId":"3574073567796453","name":"Prosperity","avatar":"https://static.tigerbbs.com/f04cc1d16570f51a2292afc487839365","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574073567796453","authorIdStr":"3574073567796453"},"themes":[],"htmlText":"Like and comment","listText":"Like and comment","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/890868925","repostId":"1187165636","repostType":4,"isVote":1,"tweetType":1,"viewCount":721,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":804920465,"gmtCreate":1627917020657,"gmtModify":1631890206723,"author":{"id":"3574073567796453","authorId":"3574073567796453","name":"Prosperity","avatar":"https://static.tigerbbs.com/f04cc1d16570f51a2292afc487839365","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574073567796453","authorIdStr":"3574073567796453"},"themes":[],"htmlText":"Like and comment","listText":"Like and comment","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/804920465","repostId":"1172320411","repostType":4,"isVote":1,"tweetType":1,"viewCount":765,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":808884009,"gmtCreate":1627569015301,"gmtModify":1631890206730,"author":{"id":"3574073567796453","authorId":"3574073567796453","name":"Prosperity","avatar":"https://static.tigerbbs.com/f04cc1d16570f51a2292afc487839365","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574073567796453","authorIdStr":"3574073567796453"},"themes":[],"htmlText":"Like and comment","listText":"Like and comment","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/808884009","repostId":"1165497040","repostType":4,"isVote":1,"tweetType":1,"viewCount":574,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":800560200,"gmtCreate":1627308762800,"gmtModify":1631890206730,"author":{"id":"3574073567796453","authorId":"3574073567796453","name":"Prosperity","avatar":"https://static.tigerbbs.com/f04cc1d16570f51a2292afc487839365","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574073567796453","authorIdStr":"3574073567796453"},"themes":[],"htmlText":"Like and comment","listText":"Like and comment","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/800560200","repostId":"2154957883","repostType":4,"isVote":1,"tweetType":1,"viewCount":995,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":177281356,"gmtCreate":1627223728275,"gmtModify":1631890206734,"author":{"id":"3574073567796453","authorId":"3574073567796453","name":"Prosperity","avatar":"https://static.tigerbbs.com/f04cc1d16570f51a2292afc487839365","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574073567796453","authorIdStr":"3574073567796453"},"themes":[],"htmlText":"Like and comment","listText":"Like and comment","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/177281356","repostId":"2153878189","repostType":4,"isVote":1,"tweetType":1,"viewCount":869,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":false}